Veteran investor and corporate executive with deep experience in private equity, growth-stage investing, and corporate governance. Elizabeth Fleming is known for sourcing technology and healthcare deals, serving on boards, and driving operational improvements at portfolio companies. Background includes an MBA and prior operating roles in finance; investment style emphasizes EBITDA expansion, strategic M&A, and governance-driven value creation.
Veteran investor and corporate executive with deep experience in private equity, growth-stage investing, and corporate governance. Elizabeth Fleming is known for sourcing technology and healthcare deals, serving on boards, and driving operational improvements at portfolio companies. Background includes an MBA and prior operating roles in finance; investment style emphasizes EBITDA expansion, strategic M&A, and governance-driven value creation.
Combines a private equity mindset with growth-stage agility, prioritizing investments in technology and healthcare where operational levers and governance can drive EBITDA expansion. Prefers control or meaningful board positions to implement strategic M&A, cost structure improvement, and performance KPIs. Capital allocation favors buyouts and growth rounds with a 3–7 year horizon, disciplined downside protection, active portfolio management, and a bias toward companies where finance-led operating initiatives unlock scalable margins.
Combines a private equity mindset with growth-stage agility, prioritizing investments in technology and healthcare where operational levers and governance can drive EBITDA expansion. Prefers control or meaningful board positions to implement strategic M&A, cost structure improvement, and performance KPIs. Capital allocation favors buyouts and growth rounds with a 3–7 year horizon, disciplined downside protection, active portfolio management, and a bias toward companies where finance-led operating initiatives unlock scalable margins.
| Trades 878 | Longs Won 608/878 69% | Profit Factor 6.99 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $799,116.49 |
| Average Win $171,951.66 | Best Trade (Mar 30) $18M | Sharpe Ratio -10.06 |
| Average Loss -$55,387.66 | Worst Trade (Aug 07) -$7.91M | Z-Score 4.33 (100%) |
| Commissions $0 | Avg. Trade Length 11m 2w 6d | Expectancy $102,040.94 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 5,464 | 4,918 | 4,372 | 3,825 | 3,279 | 2,732 | 2,186 | 1,639 | 1,093 | 546 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 90,528 | $18.62M | $27.97M | - | $9.35M | 50.23% | -7.354% |
ABBV AbbVie Inc. | 3,207 | $486,513.21 | $804,764.58 | - | $318,251.37 | 65.41% | -2.513% |
AMZN Amazon.com Inc | 9,041 | $1.72M | $2.46M | - | $739,364.69 | 43.09% | +15.321% |
AOM iShares Core 40/60 Moderate Allocation ETF | 12,121 | $558,353.36 | $594,898.7 | - | $36,545.34 | 6.55% | 0.0 |
ASML ASML Holding N.V. New York Registry Shares | 387 | $310,844.26 | $630,423 | - | $319,578.74 | 102.81% | -1.359% |
AVEM Avantis Emerging Markets Equity ETF | 263,045 | $19.98M | $23.55M | - | $3.57M | 17.85% | +0.101% |
AVGO Broadcom Inc. | 576 | $217,641 | $224,225.28 | - | $6,584.28 | 3.03% | +0.371% |
AVLV Avantis U.S. Large Cap Value ETF | 448,575 | $40.91M | $41.34M | - | $426,157.02 | 1.04% | +0.141% |
AZN AstraZeneca PLC American Depositary Shares | 1,383 | $272,744 | $234,612.12 | - | -$38,131.88 | -13.98% | -0.992% |
BASG Brown Advisory Sustainable Growth ETF | 17,676 | $470,876 | $484,888.03 | - | $14,012.03 | 2.98% | +1.981% |
BMY Bristol-Myers Squibb Company | 8,015 | $378,534.67 | $523,459.65 | - | $144,924.98 | 38.29% | +0.694% |
BRK-A Berkshire Hathaway Inc. | 1 | $517,810 | $766,600 | - | $248,790 | 48.05% | +0.21% |
BRK-B Berkshire Hathaway Inc. | 6,331 | $3.35M | $3.24M | - | -$112,483.99 | -3.36% | +0.365% |
BUFR FT Vestladder Buffer ETF-USD I | 10,137 | $322,356.6 | $372,737.49 | - | $50,380.89 | 15.63% | +0.41% |
CAT Caterpillar Inc. | 1,124 | $436,429.07 | $915,846.44 | - | $479,417.37 | 109.85% | +0.701% |
CAVA Cava Group Inc. | 363,865 | $30.55M | $23.73M | - | -$6.81M | -22.3% | -1.821% |
CBRE CBRE Group Inc. | 1,554 | $217,387.43 | $228,142.74 | - | $10,755.31 | 4.95% | -1.773% |
CGBL Capital Group Core Balanced ETF | 19,191 | $646,073.12 | $714,480.93 | - | $68,407.81 | 10.59% | -0.054% |
CGDG Capital Group Dividend Growers ETF | 7,601 | $275,319.17 | $291,422.34 | - | $16,103.17 | 5.85% | -0.234% |
CGDV Capital Group Dividend Value ETF | 293,914 | $12.08M | $14.56M | - | $2.48M | 20.52% | +0.63% |